Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
about
Pneumonia in the neutropenic cancer patientRecent developments in the management of invasive fungal infections in patients with oncohematological diseasesEfficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Application of caspofungin in China compared with amphotericin B and fluconazole.Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study.CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry.Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study.Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study.Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).Our 2014 approach to breakthrough invasive fungal infections.Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis.Posaconazole: a review of the gastro-resistant tablet and intravenous solution in invasive fungal infections.Our 2015 approach to invasive pulmonary aspergillosis.Republished: The clinical spectrum of pulmonary aspergillosis.How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation.Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples.Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis.Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele.Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study.[Strategies for antifungal treatment failure in intensive care units].Empirical caspofungin therapy in clinical practice for suspected invasive fungal disease in adults with acute lymphoblastic leukaemia.Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China.A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia.Recent Insights into the Paradoxical Effect of Echinocandins.Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.Aspergillus fumigatus devoid of cell wall β-1,3-glucan is viable, massively sheds galactomannan and is killed by septum formation inhibitors.Mitochondrial dynamics in the pathogenic mold Aspergillus fumigatus: therapeutic and evolutionary implications.Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids.What's new in diagnosis and antimicrobial therapy of febrile neutropenic patients with lung infiltrates?Consensus statement for cancer patients requiring intensive care support.
P2860
Q26827758-865D1D98-91F0-4435-A710-486B97B6201FQ28077381-04EEE042-237A-4938-9E82-997368017616Q30240770-0DB0CDA5-178D-464C-A462-0851C8133495Q30608976-8E74812C-7CC6-4FE1-B775-7D20A71CFEDDQ34182814-1DC35CDA-E493-46AA-BEEB-09C7BB9EF3D8Q34281346-C09D5338-15B9-4E34-BD3B-962B058DA9ECQ36209069-8E3AEE6F-0472-4766-B46C-5A9037016FACQ37041199-26DD8D6B-379D-4FDD-A04D-F1D8D8AD41FEQ37139319-7F7ECAF1-F73F-4E8A-89AC-86D8BB2A056BQ37150434-26043F1B-B349-4FFA-8014-B1ACABC5E40AQ37280740-2E22AC91-F262-4D27-AD45-16676E515A76Q37366095-B2CFD81C-061E-4B03-9948-4C0B00D993ABQ38207933-2F561B77-DB3C-4ADD-8169-71F0D27D2168Q38223105-6B9198B7-338F-4863-AE3E-13149E7AEBA4Q38296370-AF4AAF2A-D982-4F54-9442-2789F3668D03Q38321383-9CFBC83D-82D8-4C4E-992C-B17F755FEFBEQ38391049-95DAB7ED-23BA-4B7E-B53A-6CA11053A408Q38549796-FD63B03B-7E0F-45C1-86EB-7E0E5D432CC1Q38686517-14C1238F-6364-403B-8922-3912BB32DB0EQ38912624-BC15A355-A44E-4AD7-BEAC-AFF22910E943Q38987096-BDAEA247-3D97-4E22-A6A1-14C531BBC6FCQ39673852-63D1828C-8C06-4CD4-A480-094C163B4F81Q40041299-A31067F7-0660-432F-A4D3-66A14CC6F2BBQ40111798-725D56ED-B019-48F0-93B8-2929784B1E5EQ40119990-F6FB7EAF-D0A2-45E3-9E5C-DD42152191E3Q40562624-72554711-3DFF-4500-8AF1-56674D16062AQ41010354-8884F404-C9B1-4A6B-98AA-DF96B9E5AD21Q41580172-922EB0FB-D32A-4178-8949-8BBDD144904CQ41712164-026A8A80-6883-437C-9EEF-14895923D3D5Q49151914-3A181EE1-6F55-4674-A823-38C756FE791BQ49679966-73BF3B2C-AD6A-4775-AA50-726E0EF0667CQ50925492-9EAC3DBB-EFCB-4406-83BD-EC4FEB5D4781Q51032695-AE5BA84F-1C53-42F9-B383-539C1406FEC6Q52662725-82AC9C4E-AFB2-42A2-B246-12610D40A515Q52673294-2006BC7D-80C5-4D77-B7D8-2E8E38C2B0D3Q53061553-757F2FAD-466F-4FA2-8387-385536022307Q55049916-59F2F209-161A-441A-9E04-872A62F53415
P2860
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of invasive fungal i ...... ematology and Oncology (DGHO).
@en
Treatment of invasive fungal i ...... ectious Diseases Working Party
@nl
type
label
Treatment of invasive fungal i ...... ematology and Oncology (DGHO).
@en
Treatment of invasive fungal i ...... ectious Diseases Working Party
@nl
prefLabel
Treatment of invasive fungal i ...... ematology and Oncology (DGHO).
@en
Treatment of invasive fungal i ...... ectious Diseases Working Party
@nl
P2093
P2860
P50
P921
P1433
P1476
Treatment of invasive fungal i ...... ematology and Oncology (DGHO).
@en
P2093
Andrew J Ullmann
Angelika Böhme
Christina Rieger
Georg Maschmeyer
Gerda Silling
Gerlinde Egerer
Hans-Heinrich Wolf
Hartmut Link
Helmut Ostermann
Jens Panse
P2860
P356
10.1007/S00277-013-1867-1
P577
2013-09-12T00:00:00Z
2014-01-01T00:00:00Z